| 2026-04-15 | Recall | FDA recall, Class II: Cipla USA, Inc.. Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspe | Regulator FDA enforcement reports |
| 2026-04-15 | Recall | FDA recall, Class II: Cipla USA, Inc.. Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspe | Regulator FDA enforcement reports |
| 2026-04-08 | Trial | New trial registered: Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study | Trial register ClinicalTrials.gov |
| 2026-01-21 | Recall | FDA recall, Class II: Cipla USA, Inc.. Presence of Particulate Matter. | Regulator FDA enforcement reports |
| 2025-10-31 | Results | Results posted: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome | Trial register ClinicalTrials.gov |
| 2025-07-09 | Trial | New trial registered: Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | Trial register ClinicalTrials.gov |
| 2025-05-09 | Results | Results posted: A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide | Trial register ClinicalTrials.gov |
| 2025-03-17 | Results | Results posted: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) | Trial register ClinicalTrials.gov |
| 2025-03-17 | Trial | New trial registered: Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors | Trial register ClinicalTrials.gov |
| 2025-02-04 | Trial | New trial registered: Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula | Trial register ClinicalTrials.gov |
| 2025-02-01 | Label | FDA label revised: LANREOTIDE ACETATE (ANDA217193) | Regulator FDA drug label register |
| 2025-02-01 | Label | FDA label revised: LANREOTIDE ACETATE (ANDA217193) | Regulator FDA drug label register |
| 2024-10-11 | Label | FDA label revised: SOMATULINE DEPOT (NDA022074) | Regulator FDA drug label register |
| 2024-10-01 | Results | Results posted: Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs | Trial register ClinicalTrials.gov |
| 2024-09-23 | Trial | New trial registered: Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands | Trial register ClinicalTrials.gov |
| 2024-09-01 | Label | FDA label revised: Lanreotide Acetate (NDA215395) | Regulator FDA drug label register |
| 2024-03-05 | Results | Results posted: A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors | Trial register ClinicalTrials.gov |
| 2023-07-27 | Results | Results posted: Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 | Trial register ClinicalTrials.gov |
| 2023-06-19 | Trial | New trial registered: A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of | Trial register ClinicalTrials.gov |
| 2023-01-05 | Trial | New trial registered: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients | Trial register ClinicalTrials.gov |
| 2023-01-04 | Results | Results posted: Acromegaly Combination Treatment Study | Trial register ClinicalTrials.gov |
| 2022-09-28 | Results | Results posted: Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors | Trial register ClinicalTrials.gov |
| 2022-07-28 | Trial | New trial registered: Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy | Trial register ClinicalTrials.gov |
| 2022-06-24 | Trial | New trial registered: Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China | Trial register ClinicalTrials.gov |
| 2022-06-16 | Results | Results posted: A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula | Trial register ClinicalTrials.gov |
| 2022-05-04 | Trial | New trial registered: A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gast | Trial register ClinicalTrials.gov |
| 2022-04-27 | Trial | New trial registered: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome | Trial register ClinicalTrials.gov |
| 2022-04-22 | Results | Results posted: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly | Trial register ClinicalTrials.gov |
| 2021-10-29 | Results | Results posted: Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours | Trial register ClinicalTrials.gov |
| 2021-10-04 | Results | Results posted: A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) | Trial register ClinicalTrials.gov |
| 2021-09-30 | Results | Results posted: A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. | Trial register ClinicalTrials.gov |
| 2021-09-21 | Trial | New trial registered: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET | Trial register ClinicalTrials.gov |
| 2021-09-17 | Trial | New trial registered: Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors | Trial register ClinicalTrials.gov |
| 2021-04-21 | Trial | New trial registered: Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs | Trial register ClinicalTrials.gov |
| 2021-01-15 | Results | Results posted: Lanreotide in the Treatment of Small Bowel Motility Disorders | Trial register ClinicalTrials.gov |
| 2021-01-06 | Trial | New trial registered: Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs | Trial register ClinicalTrials.gov |
| 2020-12-30 | Results | Results posted: Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel | Trial register ClinicalTrials.gov |
| 2020-10-01 | Results | Results posted: Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. | Trial register ClinicalTrials.gov |
| 2020-09-23 | Trial | New trial registered: United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting | Trial register ClinicalTrials.gov |
| 2020-09-14 | Trial | New trial registered: Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia | Trial register ClinicalTrials.gov |
| 2020-06-11 | Trial | New trial registered: A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET | Trial register ClinicalTrials.gov |
| 2019-12-04 | Trial | New trial registered: Microbiotic Analysis in Digestive Endocrine Tumors | Trial register ClinicalTrials.gov |
| 2019-10-01 | Results | Results posted: Quality of Life in Patients With Inoperable Malignant Bowel Obstruction | Trial register ClinicalTrials.gov |
| 2019-08-22 | Trial | New trial registered: Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Ne | Trial register ClinicalTrials.gov |
| 2019-07-01 | Trial | New trial registered: Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly | Trial register ClinicalTrials.gov |
| 2019-06-07 | Results | Results posted: Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients | Trial register ClinicalTrials.gov |
| 2019-05-23 | Trial | New trial registered: Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands | Trial register ClinicalTrials.gov |
| 2019-05-13 | Trial | New trial registered: Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. | Trial register ClinicalTrials.gov |
| 2019-05-10 | Trial | New trial registered: LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) | Trial register ClinicalTrials.gov |
| 2019-05-06 | Results | Results posted: Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET | Trial register ClinicalTrials.gov |
| 2019-04-25 | Results | Results posted: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With | Trial register ClinicalTrials.gov |
| 2019-04-01 | Results | Results posted: Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruc | Trial register ClinicalTrials.gov |
| 2019-03-29 | Trial | New trial registered: Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours | Trial register ClinicalTrials.gov |
| 2018-12-27 | Trial | New trial registered: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) | Trial register ClinicalTrials.gov |
| 2018-12-14 | Results | Results posted: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly | Trial register ClinicalTrials.gov |
| 2018-07-23 | Results | Results posted: Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients | Trial register ClinicalTrials.gov |
| 2018-06-19 | Trial | New trial registered: Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel | Trial register ClinicalTrials.gov |
| 2018-02-20 | Trial | New trial registered: Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma | Trial register ClinicalTrials.gov |
| 2017-09-21 | Trial | New trial registered: A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide | Trial register ClinicalTrials.gov |
| 2017-09-18 | Results | Results posted: TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) | Trial register ClinicalTrials.gov |
| 2017-06-02 | Trial | New trial registered: A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula | Trial register ClinicalTrials.gov |
| 2017-05-06 | Trial | New trial registered: The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research | Trial register ClinicalTrials.gov |
| 2017-04-13 | Trial | New trial registered: Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors | Trial register ClinicalTrials.gov |
| 2017-03-17 | Trial | New trial registered: Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET | Trial register ClinicalTrials.gov |
| 2017-02-17 | Results | Results posted: Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour | Trial register ClinicalTrials.gov |
| 2017-02-06 | Trial | New trial registered: Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors | Trial register ClinicalTrials.gov |
| 2017-01-11 | Trial | New trial registered: Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) | Trial register ClinicalTrials.gov |
| 2017-01-06 | Trial | New trial registered: Lanreotide in the Treatment of Small Bowel Motility Disorders | Trial register ClinicalTrials.gov |
| 2016-11-25 | Trial | New trial registered: Circulating Tumor Cells and Tumor DNA in HCC and NET | Trial register ClinicalTrials.gov |
| 2016-08-08 | Trial | New trial registered: Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttr | Trial register ClinicalTrials.gov |
| 2016-07-06 | Trial | New trial registered: The MetNET-2 Trial | Trial register ClinicalTrials.gov |
| 2016-06-21 | Trial | New trial registered: Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects | Trial register ClinicalTrials.gov |
| 2016-06-07 | Trial | New trial registered: A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors | Trial register ClinicalTrials.gov |
| 2016-06-02 | Trial | New trial registered: A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours | Trial register ClinicalTrials.gov |
| 2016-04-07 | Trial | New trial registered: 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendoc | Trial register ClinicalTrials.gov |
| 2016-04-01 | Trial | New trial registered: Community-based Neuroendocrine Tumor (NET) Research Study | Trial register ClinicalTrials.gov |
| 2016-03-03 | Trial | New trial registered: Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. | Trial register ClinicalTrials.gov |
| 2016-03-03 | Trial | New trial registered: Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg | Trial register ClinicalTrials.gov |
| 2016-02-19 | Trial | New trial registered: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly | Trial register ClinicalTrials.gov |
| 2016-02-17 | Trial | New trial registered: Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours | Trial register ClinicalTrials.gov |
| 2016-02-09 | Results | Results posted: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome | Trial register ClinicalTrials.gov |
| 2016-01-11 | Trial | New trial registered: Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide A | Trial register ClinicalTrials.gov |
| 2015-12-14 | Results | Results posted: Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects | Trial register ClinicalTrials.gov |
| 2015-12-07 | Trial | New trial registered: Pasireotide LAR and Pegvisomant Study in Acromegaly | Trial register ClinicalTrials.gov |
| 2015-09-29 | Results | Results posted: Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea | Trial register ClinicalTrials.gov |
| 2015-08-14 | Results | Results posted: Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients | Trial register ClinicalTrials.gov |
| 2015-07-09 | Trial | New trial registered: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly | Trial register ClinicalTrials.gov |
| 2015-03-24 | Trial | New trial registered: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subject | Trial register ClinicalTrials.gov |
| 2015-03-24 | Trial | New trial registered: Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. | Trial register ClinicalTrials.gov |
| 2015-02-19 | Trial | New trial registered: Quality of Life in Patients With Inoperable Malignant Bowel Obstruction | Trial register ClinicalTrials.gov |
| 2015-02-18 | Results | Results posted: Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours | Trial register ClinicalTrials.gov |
| 2015-02-03 | Trial | New trial registered: Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study | Trial register ClinicalTrials.gov |
| 2015-01-30 | Trial | New trial registered: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues | Trial register ClinicalTrials.gov |
| 2015-01-21 | Results | Results posted: Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Ac | Trial register ClinicalTrials.gov |
| 2014-11-11 | Trial | New trial registered: A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) | Trial register ClinicalTrials.gov |
| 2014-10-27 | Trial | New trial registered: Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal O | Trial register ClinicalTrials.gov |
| 2014-09-04 | Trial | New trial registered: Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET | Trial register ClinicalTrials.gov |
| 2014-07-23 | Federal Register | Federal Register notice: Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability | Regulator Federal Register |
| 2014-04-30 | Trial | New trial registered: Lanreotide In Polycystic Kidney Disease Study | Trial register ClinicalTrials.gov |
| 2014-03-03 | Trial | New trial registered: Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients | Trial register ClinicalTrials.gov |